Objective To characterise the changing trends in the pharmacological management of SLE in the USA between 2007 and 2023 as ...

Future Cardiol. 2013;9(3):335-349. Research into prostacyclin analogs for the treatment of WHO Group 2 PH has been limited, likely due to the early termination of the FIRST trial. [55] This study ...

In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects.

Developing antidepressant medications that target cells in the gut may open a novel path towards effective treatment of mood ...

An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12 ...

Chronic pain casts a long shadow, impacting millions globally. While medications offer some relief, they often come with drawbacks. Enter non-pharmacological treatments like exercise, meditation, ...